MoneyWorks4Me

Biocon board to consider recommendation of final dividend

17 Apr 2018 Evaluate

With reference to the earlier intimation dated April 05, 2018 of next Board meeting, Biocon has now informed about consideration and recommendation of final dividend, if any, for the financial year 2017-18 forms part of the agenda of the meeting of Board of Directors of the company, scheduled on April 26, 2018.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1781.60
Dr. Reddys Labs. 1200.90
Cipla 1336.90
Lupin 2014.00
Zydus Lifesciences 1141.50
View more..